Influenza B virus reverse genetic backbones with improved growth properties in the EB66® cell line as basis for vaccine seed virus generation.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Vaccine

• Publication date

  2018-02-21

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.vaccine.2018.01.050PMID 29395518
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Methadone enhances human influenza A virus replication

  2017cited by this paper
• Accelerated mass production of influenza virus seed stocks in HEK-293 suspension cell cultures by reverse genetics.

  2017cited by this paper
• Development of high-yield influenza B virus vaccine viruses

  2016cited by this paper
• The EB66® cell line as a valuable cell substrate for MVA-based vaccines production.

  2016cited by this paper
• Immunogenicity and Safety of an EB66 Cell-Culture-Derived Influenza A/Indonesia/5/2005(H5N1) AS03-Adjuvanted Vaccine: A Phase 1 Randomized Trial

  2015cited by this paper
• Cell substrates for the production of viral vaccines.

  2015cited by this paper
• The role of influenza in the epidemiology of pneumonia

  2015cited by this paper
• Mouse adaptation of influenza B virus increases replication in the upper respiratory tract and results in droplet transmissibility in ferrets

  2015cited by this paper
• A clinical phase I study of an EB66 cell-derived H5N1 pandemic vaccine adjuvanted with AS03.

  2015cited by this paper
• Development of high-yield influenza A virus vaccine viruses

  2015cited by this paper
• Pandemic preparedness and response--lessons from the H1N1 influenza of 2009.

  2014cited by this paper
• Traditional and New Influenza Vaccines

  2013cited by this paper
• Human Monoclonal Antibodies Broadly Neutralizing against Influenza B Virus

  2013cited by this paper
• New technologies for influenza vaccines

  2012cited by this paper
• Pathogenic Responses among Young Adults during the 1918 Influenza Pandemic

  2012cited by this paper
• Cell-Based Influenza Vaccines

  2012cited by this paper
• Preflucel®: a Vero-cell culture-derived trivalent influenza vaccine

  2012cited by this paper
• Lessons from pandemic influenza A(H1N1): the research-based vaccine industry's perspective.

  2011cited by this paper
• Production and antigenic properties of influenza virus from suspension MDCK-siat7e cells in a bench-scale bioreactor.

  2010cited by this paper
• Production of cell culture (MDCK) derived live attenuated influenza vaccine (LAIV) in a fully disposable platform process

  2010cited by this paper
• Generation of recombinant influenza virus from plasmid DNA.

  2010cited by this paper
• The Avian EB66(R) Cell Line, Application to Vaccines, and Therapeutic Protein Production.

  2010cited by this paper
• The public's response to the 2009 H1N1 influenza pandemic.

  2010cited by this paper
• FluBlok, a next generation influenza vaccine manufactured in insect cells.

  2009cited by this paper
• Modulation of influenza virus replication by alteration of sodium ion transport and protein kinase C activity

  2008cited by this paper
• The annual impact of seasonal influenza in the US: measuring disease burden and costs.

  2007cited by this paper
• Estimation of potential global pandemic influenza mortality on the basis of vital registry data from the 1918-20 pandemic: a quantitative analysis.

  2006cited by this paper
• 1918 Influenza: the Mother of All Pandemics

  2006cited by this paper
• Mortality associated with influenza and respiratory syncytial virus in the United States.

  2003cited by this paper
• DIAGNOSIS OF LEGIONELLA INFECTION

  2002cited by this paper

• Generation of a high yield vaccine backbone for influenza B virus in embryonated chicken eggs

  2023cites this paper
• A Review of the Establishment of the Seed Lot System in the Production of Biological Products and Its Importance.

  2022cites this paper
• Cell-based influenza vaccine: current production, halal status assessment, and recommendations towards Islamic-compliant manufacturing

  2021cites this paper
• Intensified yellow fever and Zika virus production in animal cell culture

  2020cites this paper
• Immunogenicity and protective efficacy of an EB66® cell culture-derived duck Tembusu virus vaccine

  2020cites this paper
• Reverse genetics for influenza B viruses and recent advances in vaccine development.

  2020cites this paper
• High titer MVA and influenza A virus production using a hybrid fed-batch/perfusion strategy with an ATF system

  2019cites this paper
• Broadly Cross-Reactive, Nonneutralizing Antibodies against Influenza B Virus Hemagglutinin Demonstrate Effector Function-Dependent Protection against Lethal Viral Challenge in Mice

  2019cites this paper
• Poxvirus-based vector systems and the potential for multi-valent and multi-pathogen vaccines

  2018cites this paper